{"title":"粪便微生物治疗复发性难治性艰难梭菌感染与免疫功能低下患者的阳性结果相关","authors":"Eric Applebach","doi":"10.22237/CRP/1567555800","DOIUrl":null,"url":null,"abstract":"<p>A critical appraisal and clinical application of Kelly CR, Ihunnah C, Fischer M, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. <em>The American Journal of Gastroenterology</em>, 2014;<em>109</em>(7):1065-71. doi: <a href=\"https://doi.org/10.1038/ajg.2014.133\">10.1038/ajg.2014.133</a></p>","PeriodicalId":10422,"journal":{"name":"Clinical Research In Practice: The Journal of Team Hippocrates","volume":"61 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Fecal microbiota therapy in recurrent and refractory clostridium difficile infections has been associated with positive results in immunocompromised patients\",\"authors\":\"Eric Applebach\",\"doi\":\"10.22237/CRP/1567555800\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>A critical appraisal and clinical application of Kelly CR, Ihunnah C, Fischer M, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. <em>The American Journal of Gastroenterology</em>, 2014;<em>109</em>(7):1065-71. doi: <a href=\\\"https://doi.org/10.1038/ajg.2014.133\\\">10.1038/ajg.2014.133</a></p>\",\"PeriodicalId\":10422,\"journal\":{\"name\":\"Clinical Research In Practice: The Journal of Team Hippocrates\",\"volume\":\"61 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-09-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Research In Practice: The Journal of Team Hippocrates\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22237/CRP/1567555800\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Research In Practice: The Journal of Team Hippocrates","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22237/CRP/1567555800","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
Kelly CR, Ihunnah C, Fischer M等的批判性评价及临床应用。粪便菌群移植治疗免疫功能低下患者艰难梭菌感染。美国胃肠病学杂志，2014;109(7):1065-71。doi: 10.1038 / ajg.2014.133
Fecal microbiota therapy in recurrent and refractory clostridium difficile infections has been associated with positive results in immunocompromised patients
A critical appraisal and clinical application of Kelly CR, Ihunnah C, Fischer M, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. The American Journal of Gastroenterology, 2014;109(7):1065-71. doi: 10.1038/ajg.2014.133
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
